Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
Evidence of islet CADM1-mediated immune cell interactions during human type 1 diabetes
Chandan Sona, … , Laszlo Nagy, Matthew N. Poy
Chandan Sona, … , Laszlo Nagy, Matthew N. Poy
Published February 8, 2022
Citation Information: JCI Insight. 2022;7(6):e153136. https://doi.org/10.1172/jci.insight.153136.
View: Text | PDF
Clinical Research and Public Health Endocrinology

Evidence of islet CADM1-mediated immune cell interactions during human type 1 diabetes

  • Text
  • PDF
Abstract

BACKGROUND Pathophysiology of type 1 diabetes (T1D) is illustrated by pancreatic islet infiltration of inflammatory lymphocytes, including CD8+ T cells; however, the molecular factors mediating their recruitment remain unknown. We hypothesized that single-cell RNA-sequencing (scRNA-Seq) analysis of immune cell populations isolated from islets of NOD mice captured gene expression dynamics providing critical insight into autoimmune diabetes pathogenesis.METHODS Pancreatic sections from human donors were investigated, including individuals with T1D, autoantibody-positive (aAb+) individuals, and individuals without diabetes who served as controls. IHC was performed to assess islet hormones and both novel and canonical immune cell markers that were identified from unbiased, state-of-the-art workflows after reanalyzing murine scRNA-Seq data sets.RESULTS Computational workflows identified cell adhesion molecule 1–mediated (Cadm1-mediated) homotypic binding among the most important intercellular interactions among all cell clusters, as well as Cadm1 enrichment in macrophages and DCs from pancreata of NOD mice. Immunostaining of human pancreata revealed an increased number of CADM1+glucagon+ cells adjacent to CD8+ T cells in sections from T1D and aAb+ donors compared with individuals without diabetes. Numbers of CADM1+CD68+ peri-islet myeloid cells adjacent to CD8+ T cells were also increased in pancreatic sections from both T1D and aAb+ donors compared with individuals without diabetes.CONCLUSION Increased detection of CADM1+ cells adjacent to CD8+ T cells in pancreatic sections of individuals with T1D and those who were aAb+ validated workflows and indicated CADM1-mediated intercellular contact may facilitate islet infiltration of cytotoxic T lymphocytes and serve as a potential therapeutic target for preventing T1D pathogenesis.FUNDING The Johns Hopkins All Children’s Foundation Institutional Research Grant Program, the National Natural Science Foundation of China (grant 82071326), and the Deutsche Forschungsgemeinschaft (grants 431549029–SFB1451, EXC2030–390661388, and 411422114-GRK2550).

Authors

Chandan Sona, Yu-Te Yeh, Andreas Patsalos, Laszlo Halasz, Xin Yan, Natalia L. Kononenko, Laszlo Nagy, Matthew N. Poy

×

Figure 3

Increased number of CADM1+CD45+ cells within the pancreatic islet during T1D.

Options: View larger image (or click on image) Download as PowerPoint
Increased number of CADM1+CD45+ cells within the pancreatic islet during...
(A) Immunostaining of paraffin-embedded pancreata from individuals in the Non group for CADM1 (cyan), insulin (green), and GCG (red). Scale bar: 20 μm. (B) Immunostaining of paraffin-embedded pancreata from individuals in the Non, aAb+, and T1D groups for CADM1 (red) and CD45 (green). Scale bar: 50 μm. (C) Quantification of the number of CADM1+CD45+ cells within the islet periphery (n = 5 per group). (D) Quantification of the number of CD45+ adjacent to CADM1+ cells per area pancreas (n = 5 per group). One-way ANOVA was performed using GraphPad Prism, version 7, software for comparisons of 3 groups. Post hoc statistical analyses were performed using the Tukey multiple comparisons test. Results are presented as mean ± SEM. *P < 0.05; ***P < 0.001. ad., adjacent.

Copyright © 2025 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts